Study under review: Effects of Omega-3-Polyunsaturated Fatty on Endothelial Function in Patients with Peripheral Arterial Disease: A Randomized, Placebo-Controlled, Double-Blind Trial.
Peripheral artery disease is a disease in which one or more of the peripheral arteries are partially or completely blocked, often referred to as occluded. It is estimated that peripheral artery disease affects over 200 million individuals worldwide. The blocked/occluded vessels are primarily the result of plaques in the vasculature, which not only restricts blood flow but also greatly reduces the ability of the vasculature to dilate in response to circulation needs.
Long chain, omega-3-polyunsaturated (omega-3) fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been investigated as potential therapeutic options for peripheral artery disease. These long chain omega-3s have been shown to improve blood flow and endothelial function, as assessed by flow-mediated dilation (FMD) in previous studies. Recently, a meta-analysis was conducted, showing that this effect is observed in multiple trials. FMD is a measurement of how responsive the endothelium is to increases in blood flow. The basics of FMD are covered in Figure 1. While it’s measured more in studies than in the clinic, FMD is a useful measurement for predicting disease outcomes, such as cardiovascular events or cardiovascular death.
Despite earlier evidence showing beneficial effects of omega-3s on FMD, there is a paucity of evidence among people with peripheral artery disease. The present study was a randomized, single-center, double-blind, placebo controlled trial examining the effect of omega-3 supplementation on endothelial function in people with peripheral artery disease.
Peripheral artery disease is a disease of the peripheral vasculature involving endothelial dysfunction. Omega-3 fatty acids have been shown to improve endothelial function in earlier trials involving people without peripheral artery disease. The present study was a randomized, double-blind, placebo controlled trial examining the effect of omega-3 supplementation on endothelial function among people with peripheral artery disease.
Other Articles in Issue #59 (September 2019)
Losing weight is more important than reducing saturated fat intake for improving atherogenic lipids
Cutting saturated fat or replacing it with polyunsaturated fat is one way to improve blood lipids. However, lipids in people with higher BMI don't budge as much compared to those with lower BMI.
Mini: The best diets to control blood lipids in people with diabetes
Improving blood lipid profile is especially important for people with diabetes, who are already at a higher risk for cardiovascular problems. Are some diets better than others at achieving this goal?
Does essential amino acid supplementation cause insulin resistance?
Aging brings with it a loss in muscle mass, which can negatively impact insulin sensitivity. Amino acid supplementation can help maintain muscle mass, but some evidence also suggests it may promote insulin resistance. Are older adults stuck between a rock and a hard place?
Does the feeding window matter for muscle mass?
Time-restricted feeding (TRF) may have a negative impact on muscle mass, at least in theory. This study put the question to the test by examining both TRF’s and HMB supplementation’s effects in resistance-training women.
Vitamin D dosing downer: implications for bone density
More isn't always better when it comes to vitamin D preventing bone density loss.
Mini: The latest evidence on the nutritional interventions’ effects on cardiovascular health
How good is the evidence concerning different nutritional interventions' impact on cardiovascular endpoints? A recent umbrella review explored the issue.
Beyond brawn: can protein supplementation fuel aerobic improvement?
It's well known that protein supplementation pairs well with resistance training, but can casein outperform carbs when paired with cardio?